TR200400635T2 - Çok nesilli kinaz proteinlerin modüle edilmesi - Google Patents
Çok nesilli kinaz proteinlerin modüle edilmesiInfo
- Publication number
- TR200400635T2 TR200400635T2 TR2004/00635T TR200400635T TR200400635T2 TR 200400635 T2 TR200400635 T2 TR 200400635T2 TR 2004/00635 T TR2004/00635 T TR 2004/00635T TR 200400635 T TR200400635 T TR 200400635T TR 200400635 T2 TR200400635 T2 TR 200400635T2
- Authority
- TR
- Turkey
- Prior art keywords
- methods
- compound
- generation
- protein
- generation kinase
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title abstract 5
- 102000020233 phosphotransferase Human genes 0.000 title abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 5
- 230000000694 effects Effects 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000030833 cell death Effects 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
Abstract
Çok nesilli kinaz protein ihtiva eden hücrenin bileşikle temas ettirilmesi, bileşiğin, çok nesilli kinaz proteinin aktivitesini azaltıp azaltmadığının belirlenmesi ve bileşiğin, hücre yaşamını destekleyip desteklemediğinin belirlenmesi aşamalarını kapsayan çok nesilli bir kinaz proteinin aktivitesini modüle eden ve hücre yaşamını ya da hücre ölümünü destekleyen bileşiklerin tespit edilmesine yönelik metotlar sağlanmıştır. Nörodejeneratif bozuklukların ve/veya iltihabın tedavisinde yararlı olabilen bileşiklerin belirlenmesine yönelik metotlar da sağlanmıştır. Proteinin ya da protein ihtiva eden bir hücrenin buluşa ait bir indeno- ya da indelo- bileşiği ile temas ettirilmesini kapsayan çok nesilli kinaz proteinin aktivitesinin modüle edilmesine yönelik metotlar sağlanmıştır. Nörodejeneratif bozuklukların ve/veya iltihabın tedavisine yönelik metotlar da sağlanmıştır.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9798098P | 1998-08-26 | 1998-08-26 | |
PCT/US1999/018864 WO2000013015A1 (en) | 1998-08-26 | 1999-08-18 | Modulating multiple lineage kinase proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200400635T2 true TR200400635T2 (tr) | 2005-10-21 |
Family
ID=22266038
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/00635T TR200400635T2 (tr) | 1998-08-26 | 1999-08-18 | Çok nesilli kinaz proteinlerin modüle edilmesi |
TR2001/00589T TR200100589T2 (tr) | 1998-08-26 | 1999-08-18 | Çok nesilli kinaz proteinlerin modüle edilmesi. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00589T TR200100589T2 (tr) | 1998-08-26 | 1999-08-18 | Çok nesilli kinaz proteinlerin modüle edilmesi. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1105728B1 (tr) |
JP (1) | JP2002523780A (tr) |
KR (1) | KR100700028B1 (tr) |
CN (3) | CN1206535C (tr) |
AT (1) | ATE293254T1 (tr) |
AU (1) | AU765637B2 (tr) |
BG (1) | BG105360A (tr) |
BR (1) | BR9913190A (tr) |
CA (1) | CA2339539A1 (tr) |
CZ (1) | CZ2001701A3 (tr) |
DE (1) | DE69924738T2 (tr) |
DK (1) | DK1105728T3 (tr) |
EA (2) | EA200500934A1 (tr) |
ES (1) | ES2241316T3 (tr) |
HK (1) | HK1037722A1 (tr) |
HU (1) | HUP0103079A3 (tr) |
NO (1) | NO20010389L (tr) |
NZ (1) | NZ509612A (tr) |
PL (1) | PL346246A1 (tr) |
PT (1) | PT1105728E (tr) |
SK (1) | SK2542001A3 (tr) |
TR (2) | TR200400635T2 (tr) |
UA (1) | UA74772C2 (tr) |
WO (1) | WO2000013015A1 (tr) |
ZA (1) | ZA200100835B (tr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US6841567B1 (en) | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
US7122679B2 (en) * | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
CZ2003680A3 (cs) * | 2000-08-11 | 2003-11-12 | Cephalon, Inc. | Způsob modulace kinasových proteinů s vícenásobnou vazbou a vyhledávání sloučenin modulujících kinasové proteiny s vícenásobnou vazbou |
US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
FR2826653B1 (fr) * | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2003052395A (ja) * | 2001-08-09 | 2003-02-25 | Japan Tissue Engineering:Kk | 移植適正判定方法 |
AR069501A1 (es) | 2007-11-30 | 2010-01-27 | Genentech Inc | Anticuerpos anti- vegf (factor de crecimiento endotelial vascular) |
JP2011517339A (ja) * | 2008-02-04 | 2011-06-02 | ガラパゴス・ナムローゼ・フェンノートシャップ | 神経変性疾患の治療に有用な分子標的及び化合物並びにこれらの同定方法 |
US20100056609A1 (en) * | 2008-08-26 | 2010-03-04 | Washington University | Methods and compositions for inhibition of axonal degeneration by modulation of the dlk/jnk pathway |
AU2015202365B2 (en) * | 2008-10-22 | 2016-11-24 | Genentech, Inc. | Modulation of axon degeneration |
US9101645B2 (en) | 2008-10-22 | 2015-08-11 | Genentech, Inc. | Modulation of axon degeneration |
MX2012004638A (es) * | 2009-10-22 | 2012-07-04 | Genentech Inc | Modulacion de degeneracion de axones. |
ES2385157B1 (es) * | 2010-02-25 | 2013-07-08 | Universidad Del País Vasco | Compuestos para el tratamiento de alzheimer. |
EP2852388A4 (en) | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
CN109060472A (zh) * | 2018-07-20 | 2018-12-21 | 上海市农业科学院 | 一种适于荧光染色的草菇菌褶组织切片的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5475110A (en) * | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
-
1999
- 1999-08-18 HU HU0103079A patent/HUP0103079A3/hu unknown
- 1999-08-18 TR TR2004/00635T patent/TR200400635T2/tr unknown
- 1999-08-18 SK SK254-2001A patent/SK2542001A3/sk unknown
- 1999-08-18 DE DE69924738T patent/DE69924738T2/de not_active Expired - Lifetime
- 1999-08-18 AT AT99943759T patent/ATE293254T1/de active
- 1999-08-18 KR KR1020017002385A patent/KR100700028B1/ko active IP Right Grant
- 1999-08-18 ES ES99943759T patent/ES2241316T3/es not_active Expired - Lifetime
- 1999-08-18 BR BR9913190-0A patent/BR9913190A/pt not_active Application Discontinuation
- 1999-08-18 EA EA200500934A patent/EA200500934A1/ru unknown
- 1999-08-18 PL PL99346246A patent/PL346246A1/xx not_active Application Discontinuation
- 1999-08-18 TR TR2001/00589T patent/TR200100589T2/tr unknown
- 1999-08-18 DK DK99943759T patent/DK1105728T3/da active
- 1999-08-18 CA CA002339539A patent/CA2339539A1/en not_active Abandoned
- 1999-08-18 WO PCT/US1999/018864 patent/WO2000013015A1/en active IP Right Grant
- 1999-08-18 JP JP2000567949A patent/JP2002523780A/ja active Pending
- 1999-08-18 EA EA200100278A patent/EA006648B1/ru not_active IP Right Cessation
- 1999-08-18 NZ NZ509612A patent/NZ509612A/en not_active IP Right Cessation
- 1999-08-18 CN CNB998101354A patent/CN1206535C/zh not_active Expired - Fee Related
- 1999-08-18 CZ CZ2001701A patent/CZ2001701A3/cs unknown
- 1999-08-18 AU AU56793/99A patent/AU765637B2/en not_active Ceased
- 1999-08-18 EP EP99943759A patent/EP1105728B1/en not_active Expired - Lifetime
- 1999-08-18 CN CNA2004100491086A patent/CN1589788A/zh active Pending
- 1999-08-18 UA UA2001031963A patent/UA74772C2/uk unknown
- 1999-08-18 PT PT99943759T patent/PT1105728E/pt unknown
- 1999-08-18 CN CNA200610099703XA patent/CN1879617A/zh active Pending
-
2001
- 2001-01-23 NO NO20010389A patent/NO20010389L/no not_active Application Discontinuation
- 2001-01-30 ZA ZA2001/00835A patent/ZA200100835B/en unknown
- 2001-03-19 BG BG105360A patent/BG105360A/bg unknown
- 2001-11-23 HK HK01108292A patent/HK1037722A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200400635T2 (tr) | Çok nesilli kinaz proteinlerin modüle edilmesi | |
DE69837529D1 (de) | Proteinmarker für lungenkrebs und deren verwendung | |
EA200200105A1 (ru) | СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ; | |
DE69941800D1 (de) | Salze von Liponsaürederivaten und deren Verwendung bei der Behandlung von Krankheiten | |
TR200101549T2 (tr) | p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar. | |
TR200001546T2 (tr) | Serin/treonin protein kinaz fonksiyonunu modüle etmek için azabenzimidazol esaslı bileşikler. | |
DE69432055T2 (de) | Verwendung von einem mittel, das tyrosinphosphorylierung moduliert, zur modulation der durchlässigkeit einer physiologischen sperrschicht | |
ATE391177T1 (de) | Zusammensetzungen und methoden zur modulierung der zellulären aktivität von nf-kappab | |
WO2005010215A3 (en) | Methods for identifying tolerance modulatory compounds and uses therefor | |
DE69825625D1 (de) | Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen | |
WO2002031511A3 (en) | Modulation of ligand binding/enzymatic activity of alpha beta proteins | |
BR9703386A (pt) | Células aviárias imortalizadas | |
ATE499445T1 (de) | Menschliche ubiqutin ligase e3. verwendung für die modulation von nf-kappa b | |
DE69733861D1 (de) | Verwendung von neuronalem apoptose-inhibitorprotein | |
AU2002248180A1 (en) | Non-apoptotic forms of cell death and methods of modulation | |
WO2002014536A3 (en) | Odulating multiple lineage kinase proteins | |
WO2004109290A3 (en) | Methods for identifying modulators of kinesin activity | |
AU2172597A (en) | Protein phosphatase-1 catalytic subunit interactions | |
TR200201251T2 (tr) | Omega zinciri tadil edilmiş 15-hidroksieikosatetraenoik asit türevleri ve bunların göz kurumasının iyileştirilmesi için kullanım yöntemleri | |
DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
ATE258064T1 (de) | Verwendung von antileukoprotease zur behandlung von endometriose | |
DE69735676D1 (de) | Proteinmarker für ösophaguskrebs | |
ATE422507T1 (de) | Modifizierte hydrogele und ihre verwendung | |
PT1169054E (pt) | Produtos e metodos para tratar doencas relacionadas com ptp lar | |
WO2001041781A3 (en) | Id protein inhibitors for treating ocular diseases |